DNA Sequencing Detects Residual Leukemia
GenomeWeb Daily News reports that DNA sequencing is able to track cancerous blood cells in leukemia patients even when currently used methods cannot. The findings, published on May 16 in the journal Science Translational Medicine, suggest that high-throughput sequencing could improve the diagnosis and post-treatment monitoring of leukemia. The sequencing-based method is more sensitive than one of the two typical methods of detecting the malignant cells (flow cytometry) and cheaper and faster than the other (quantitative real-time PCR).
GenomeWeb notes that the Fred Hutchinson Cancer Research Center, one of the research institutions involved in the study, has applied for patents related to the technique.
Keep Reading
Most Popular
Large language models can do jaw-dropping things. But nobody knows exactly why.
And that's a problem. Figuring it out is one of the biggest scientific puzzles of our time and a crucial step towards controlling more powerful future models.
The problem with plug-in hybrids? Their drivers.
Plug-in hybrids are often sold as a transition to EVs, but new data from Europe shows we’re still underestimating the emissions they produce.
Google DeepMind’s new generative model makes Super Mario–like games from scratch
Genie learns how to control games by watching hours and hours of video. It could help train next-gen robots too.
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.